The Venture Codex Logo

The Venture Codex

Bioverge

447 Sutter St Ste 405, San Francisco, CA, 94108, United States

Overview

Venture capital firm investing in emerging healthcare startups.

Founded

2016

Deals ยท 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed

Geographic focus

United States

Sector focus

Biotechnology
Health Care
Venture Capital

Investment portfolio

4rounds
NAMEDATESIZE
Modulo Bio
Jun 2023Participated
$8 MOther Equity
Jelikalite
Feb 2023Participated
$0.76 MOther Equity
Eigen Therapeutics
Dec 2022Participated
$7 MSeed
EnClear Therapies
Mar 2019Participated
$2 MSeed
Modulo Bio
Jun 2023Participated
$8 MOther Equity
Jelikalite
Feb 2023Participated
$0.76 MOther Equity
Eigen Therapeutics
Dec 2022Participated
$7 MSeed
EnClear Therapies
Mar 2019Participated
$2 MSeed
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Bioverge: 4 funding rounds are recorded in the selected participation categories.All available history.
Bioverge: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed02
Other Equity02

Monthly Deal Activity

Bioverge: 4 deals are recorded across 92 months.All available history.
Bioverge: 4 deals are recorded across 92 months. All available history
MonthDeals
Mar '191
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '221
Jan '230
Feb '231
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Bioverge: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Bioverge: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4
Consumer & Lifestyle1

Deal Size Distribution

Bioverge: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Bioverge: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M2
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Bioverge: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Bioverge: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Bioverge: 13 co-investors are shown, with Builders VC sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Bioverge: 13 co-investors are shown, with Builders VC sharing 2 recorded deals. All available history
Co-investorShared deals
Builders VC2
Hawktail2
Alumni Ventures1
Cantos1
First Round1
Initialized Capital1
Mount Pleasant Ventures1
New York Ventures1
Presight Capital1
Refactor Capital1
Sanford Biosciences1
Spacecadet Ventures1
Thiel Capital1

Investment Strategy

Bioverge: Led accounts for 0% and participating for 100% of round participation.All available history.
Bioverge: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating4100%
Bioverge: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Bioverge: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Marianne Santaguida

Entrepreneur In Residence

Neil Littman

Founding Partner & CEO

Rick Gibb

Founding Partner & COO